Scarica l'app Stockscreener
12.10
0.50%
0.06
Dopo l'orario di chiusura:
12.11
0.010
+0.08%
Precedente Chiudi:
$12.04
Aprire:
$11.94
Volume 24 ore:
3.22M
Relative Volume:
0.73
Capitalizzazione di mercato:
$5.98B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
30.25
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+2.11%
1M Prestazione:
+4.04%
6M Prestazione:
-5.47%
1 anno Prestazione:
-16.78%
Intervallo 1D:
$11.81
$12.19
Intervallo di 1 settimana:
$11.71
$12.19
Portata 52W:
$11.11
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
12.10 | 5.98B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
166.63 | 75.18B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.22 | 41.69B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.89 | 40.87B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.01 | 24.94B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
146.76 | 14.86B | 2.24B | 385.90M | 440.10M | 3.73 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. - Benzinga
UK Veterinary Medicine Market May See a Big Move | Norbrook, Merck, Elanco - openPR
Is Elanco Animal Health Incorporated (ELAN) the Most Undervalued Stock to Invest in for Under $20? - Insider Monkey
12 Most Undervalued Stocks to Invest in for Under $20 - Insider Monkey
2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN (Elanco Animal Health) Deferred Tax : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Elanco Animal Health's SWOT analysis: stock outlook amid product challenges - MSN
ELAN (Elanco Animal Health) Long-Term Debt : $4,313 Mil (As of Sep. 2024) - GuruFocus.com
Elanco Animal Health’s SWOT analysis: stock outlook amid product challenges - Investing.com Nigeria
Companion Animal Ear Infection Treatment Market SWOT Analysis by Leading Expert: Elanco, Vetoquinol, Ceva - openPR
2025-01-15 | Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
Veterinary Vaccines Market SWOT Analysis by Leading Expert: Virbac, Elanco, HIPRA - openPR
ELAN (Elanco Animal Health) Change In Working Capital : $239 Mil (TTM As of Sep. 2024) - GuruFocus.com
2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing
Is Elanco Animal Health (ELAN) the Best Medical Stock to Buy Under $20? - Insider Monkey
12 Best Medical Stocks To Buy Under $20 - Insider Monkey
Elanco Animal Health Incorporated (NYSE:ELAN) Stock Position Increased by Harbor Capital Advisors Inc. - MarketBeat
Elanco Animal Health (FRA:5EA) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jan. 10, 2025) - GuruFocus.com
Elanco Animal Health (FRA:5EA) Gross Profit : €2,236 Mil (TTM As of Sep. 2024) - GuruFocus.com
Elanco Animal Health Incorporated (NYSE:ELAN) Receives $16.43 Average Target Price from Brokerages - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of “Hold” from Analysts - Defense World
Animal Health Business Research Report 2024-2030 Featuring Major PlayersBayer, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Heska, Merck, Nutreco, Vetiquinol, Virbac, and Zoetis - Yahoo Finance
17,250 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Purchased by Everence Capital Management Inc. - Defense World
Elanco Animal Health (NYSE:ELAN) Reaches New 52-Week Low on Analyst Downgrade - Defense World
Elanco Animal Health (FRA:5EA) Other Long Term Assets : €272 Mil (As of Sep. 2024) - GuruFocus.com
Douglas Lane & Associates LLC Trims Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry - GlobeNewswire Inc.
Elanco Animal Health (NYSE:ELAN) Sets New 1-Year Low on Analyst Downgrade - MarketBeat
2025-01-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
Elanco Animal Health (NYSE:ELAN) Takes On Some Risk With Its Use Of Debt - Simply Wall St
Versant Capital Management Inc Sells 1,241 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Stifel Nicolaus Lowers Elanco Animal Health (NYSE:ELAN) Price Target to $18.00 - MarketBeat
Veterinary Oncology Market Generated Opportunities, Future - openPR
Principal Financial Group Inc. Sells 21,919 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
2025-01-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
JPMorgan Chase & Co. Increases Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Animal Hormones Market Forecast: Size, Share, Growth, Key - openPR
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.42%
1.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):